Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20952687 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma;   Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: umbilical cord blood transplantation;   Drug: Allopurinol;   Drug: fludarabine phosphate;   Drug: Cyclophosphamide;   Radiation: Total body irradiation;   Biological: Treg infusion;   Drug: Sirolimus
2 Recruiting Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Umbilical Cord Blood Regulatory T cells Therapy;   Drug: Insulin

Study has passed its completion date and status has not been verified in more than two years.